WHO ICTRP trial
To study the medicinal effectiveness of SafÅ«f Hajar-al YahÅ«d in patients of…
CTRI/2015/10/006276 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2015/10/006276 |
|---|---|
| Public title | To study the medicinal effectiveness of SafÅ«f Hajar-al YahÅ«d in patients of HasÄ?h al-Kulya (Nephrolithiasis). |
| Scientific title | Anti-nephrolithic potential of SafÅ«f Hajar-al YahÅ«d (Unani Pharmacopeial Formulation) in patients of HasÄ?h al-Kulya (Nephrolithiasis) |
| Primary sponsor | Central Council for Research in Unani Medicine CCRUM New Delhi |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: N200- Calculus of kidney Health Condition 2: null- HasÄ?h al-Kulya (Nephrolithiasis) |
| Interventions | Intervention1: Safūf Hajar-al Yahūd: 5g, BD Orally, with water after meals for a period of 8 weeks Control Intervention1: NIL: NA |
| Registration date | Oct 19, 2015 |
| Target size | 30 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: